A clustered family history of breast, ovarian, and colon cancers appropriately triggered germline testing, with BRCA1 mutation status informing individualized risk stratification and counseling.

We talked to experts about new research connecting mutations in BRCA genes to other forms of cancer besides breast and ovarian. If you typically think of BRCA gene mutations along with certain breast ...

Breast cancer is a prevalent cancer in women across the globe. Although a majority of the instances are isolated, hereditary cases associated with genetic mutations are found in 5-10 percent. Of these ...

Risk assessments for cancers related to BRCA mutations could save lives. Annually, about 247,200 cases of breast cancer are diagnosed in the U.S. and nearly 42,000 people die each year from breast ...

In young BRCA carriers who survived breast cancer, assisted reproductive techniques (ART) did not increase the risk of disease recurrence or adversely affect pregnancy outcomes, findings of an ...

(WASHINGTON, June 13, 2025) – Women with breast cancer who were also carriers of the BRCA1 or BRCA2 mutation and received textured breast implants as part of their reconstructive surgery after ...

Of the more than 3 million people with breast cancer in the United Stated, about 10 percent carry an inherited mutation in their BRCA1 gene. In health, the gene is responsible for suppressing tumors.

Should screening for BRCA1/2 mutations be expanded to all women diagnosed with breast cancer? This is the recommendation put forth in recent guidelines from the American Society of Clinical Oncology ...

Patients with BRCA-mutant breast cancer had a significantly higher risk of breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL), a large cohort study showed. BRCA1/2 mutations conferred ...

Breast-conserving therapy for BRCA1/2 mutation carriers has higher risks of future breast cancers than the general population, but most patients avoid another cancer event, and many remain bilateral ...

Thoracic Radiotherapy Improves the Survival in Patients With EGFR-Mutated Oligo-Organ Metastatic Non–Small Cell Lung Cancer Treated With Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitors: A ...

VANESSA THANK YOU. AND NOW TO THE STORY OF A WOMAN WHO IS NOT ONLY A BREAST CANCER ADVOCATE, SHE’S AN AUTHOR AND NOW A MOVIE PRODUCER. HER FIRST FULL LENGTH FILM TACKLES THE DECISIONS A WOMAN WITH A ...